Skip to main content

What the FDA labels say about taking them together

Dimenhydrinate and diphenhydramine

Dimenhydrinate's FDA label of August 17, 2026 names diphenhydramine in its contraindications (prescription label) section; the diphenhydramine label PlainMeds reads does not name dimenhydrinate.

Check it at the source: the dimenhydrinate FDA label on DailyMed (effective August 17, 2026); the diphenhydramine FDA label on DailyMed (effective November 18, 2025, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.).

What does the dimenhydrinate label say about diphenhydramine?

Dimenhydrinate label, contraindications (prescription label)

CONTRAINDICATIONS Neonates and patients with a history of hypersensitivity to dimenhydrinate or its components (diphenhydramine or 8-chlorotheophylline) should not be treated with dimenhydrinate.

Source: FDA drug label (Motion Sickness), Strategic Sourcing Services LLC, effective August 17, 2026 (SPL set be8f91d4-6e4f-4d47-93e9-7fb91160b7df), via openFDA; the full label on DailyMed

What does the diphenhydramine label say about dimenhydrinate?

Diphenhydramine's label (effective November 18, 2025) does not name dimenhydrinate in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Diphenhydramine Hydrochloride), Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., effective November 18, 2025 (SPL set 6178d3a1-0741-49a4-be81-c4f7d29f8b2a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

1Dimenhydrinate generic labelers
20Diphenhydramine generic labelers
DimenhydrinateDiphenhydramine
Labeled forNausea and vomitingCough and cold, Allergies, Pain
Boxed warningNoNo
Pharmacy cost (NADAC)$0.0575 per tablet 50 mg tablet$0.898 per mL 50 mg/mL vial
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?